Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

87 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 1000

Institute for Genetics of Heart Diseases (IfGH), MÃ¼nster, Germany

ABSTRACT: Organisation EGAO00000000932

PROVIDER: EGAO00000000932 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Publications

A Mutation in the G-Protein Gene <i>GNB2</i> Causes Familial Sinus Node and Atrioventricular Conduction Dysfunction.

Stallmeyer Birgit B Kuß Johanna J Kotthoff Stefan S Zumhagen Sven S Vowinkel Kirsty K Rinné Susanne S Matschke Lina A LA Friedrich Corinna C Schulze-Bahr Ellen E Rust Stephan S Seebohm Guiscard G Decher Niels N Schulze-Bahr Eric E

Circulation research 20170220 10

<h4>Rationale</h4>Familial sinus node and atrioventricular conduction dysfunction is a rare disorder that leads to paroxysmal dizziness, fatigue, and syncope because of a temporarily or permanently reduced heart rate. To date, only a few genes for familial sinus and atrioventricular conduction dysfunction are known, and the majority of cases remain pathogenically unresolved.<h4>Objective</h4>We aim to identify the disease gene in a large 3-generation family (n=25) with autosomal dominant sinus n ...[more]

PMID: 28219978

Similar Datasets

Institute of Human Genetics, Bonn, Germany

Project description:Organisation EGAO00000000477

| EGAO00000000477 | EGA

Systems Genetics for Mechanistic Discovery in Heart Diseases.

Project description:Cardiovascular diseases are the leading cause of death worldwide. Complex diseases with highly heterogenous disease progression among patient populations, cardiovascular diseases feature multifactorial contributions from both genetic and environmental stressors. Despite significant effort utilizing multiple approaches from molecular biology to genome-wide association studies, the genetic landscape of cardiovascular diseases, particularly for the nonfamilial forms of heart failure, is still poorly understood. In the past decade, systems-level approaches based on omics technologies have become an important approach for the study of complex traits in large populations. These advances create opportunities to integrate genetic variation with other biological layers to identify and prioritize candidate genes, understand pathogenic pathways, and elucidate gene-gene and gene-environment interactions. In this review, we will highlight some of the recent progress made using systems genetics approaches to uncover novel mechanisms and molecular bases of cardiovascular pathophysiological manifestations. The key technology and data analysis platforms necessary to implement systems genetics will be described, and the current major challenges and future directions will also be discussed. For complex cardiovascular diseases, such as heart failure, systems genetics represents a powerful strategy to obtain mechanistic insights and to develop individualized diagnostic and therapeutic regiments, paving the way for precision cardiovascular medicine.

| S-EPMC7286104 | biostudies-literature

National Institute of Genetics

Project description:Organisation EGAO00000000712

| EGAO00000000712 | EGA

National Cancer Institute Prostate Cancer Genetics Workshop.

Project description:Compelling evidence supports a genetic component to prostate cancer susceptibility and aggressiveness. Recent genome-wide association studies have identified more than 30 single-nucleotide polymorphisms associated with prostate cancer susceptibility. It remains unclear, however, whether such genetic variants are associated with disease aggressiveness--one of the most important questions in prostate cancer research today. To help clarify this and substantially expand research in the genetic determinants of prostate cancer aggressiveness, the first National Cancer Institute Prostate Cancer Genetics Workshop assembled researchers to develop plans for a large new research consortium and patient cohort. The workshop reviewed the prior work in this area and addressed the practical issues in planning future studies. With new DNA sequencing technology, the potential application of sequencing information to patient care is emerging. The workshop, therefore, included state-of-the-art presentations by experts on new genotyping technologies, including sequencing and associated bioinformatics issues, which are just beginning to be applied to cancer genetics.

| S-EPMC3096727 | biostudies-literature

Institute for Pathology, Klinikum rechts der Isar, TU MÃ¼nchen

Project description:Organisation EGAO00000000834

| EGAO00000000834 | EGA

Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop.

Project description:Right ventricular dysfunction is a hallmark of advanced pulmonary vascular, lung parenchymal, and left heart disease, yet the underlying mechanisms that govern (mal)adaptation remain incompletely characterized. Owing to the knowledge gaps in our understanding of the right ventricle (RV) in health and disease, the National Heart, Lung, and Blood Institute (NHLBI) commissioned a working group to identify current challenges in the field. These included a need to define and standardize normal RV structure and function in populations; access to RV tissue for research purposes and the development of complex experimental platforms that recapitulate the in vivo environment; and the advancement of imaging and invasive methodologies to study the RV within basic, translational, and clinical research programs. Specific recommendations were provided, including a call to incorporate precision medicine and innovations in prognosis, diagnosis, and novel RV therapeutics for patients with pulmonary vascular disease.

| S-EPMC8375628 | biostudies-literature

LMU MÃ¼nchen

Project description:Organisation EGAO00000001034

| EGAO00000001034 | EGA

Institute for Medical Informatics, Biometry and Epidemiology, Essen, Germany

Project description:Organisation EGAO00000000476

| EGAO00000000476 | EGA

Max-Planck-Institute for Molecular Genetics

Project description:Organisation EGAO00000000748

| EGAO00000000748 | EGA

Max Planck Institute for molecular Genetics

Project description:Organisation EGAG00000000008